The Europe N-Hydroxysuccinimide market size was valued at US$ 85.4 million in 2024 and is projected to reach US$ 122.6 million by 2030, at a CAGR of 6.2% during the forecast period 2024-2030.

As the demand for advanced biochemical reagents continues to rise across pharmaceutical research, biotechnology, and academic institutions, the spotlight is on the key suppliers who are driving innovation, quality, and reliable supply chains. In this blog, we profile the Top 10 Companies in the Europe N-Hydroxysuccinimide Market—a mix of chemical majors, specialty manufacturers, and life science leaders shaping the future of peptide synthesis and protein modification solutions.

---

🔟 1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: N-Hydroxysuccinimide (NHS), high-purity reagents for peptide synthesis

Merck KGaA stands as a global leader in life science reagents, offering high-quality N-Hydroxysuccinimide for research and industrial applications. Their products support critical processes in drug development and bioconjugation across Europe’s thriving pharmaceutical sector.

Innovation Initiatives:

• Advanced reagent formulations for protein modification

• Partnerships with research institutions for custom synthesis

• Commitment to sustainable laboratory chemical production

Download FREE Sample Report: Europe N-Hydroxysuccinimide Market – View in Detailed Research Report

---

9️⃣ 2. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Specialty intermediates including N-Hydroxysuccinimide derivatives

BASF SE leverages its vast chemical expertise to supply high-performance intermediates essential for the pharmaceutical and cosmetics industries. The company plays a vital role in supporting Europe’s innovative drug manufacturing ecosystem.

Innovation Initiatives:

• Development of high-purity chemical building blocks

• Focus on sustainable production technologies

• Collaboration with biotech firms for tailored solutions

---

8️⃣ 3. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: High-purity N-Hydroxysuccinimide, specialty chemicals for life sciences

Evonik Industries AG is recognized for its advanced materials and chemical solutions that enable precise biochemical reactions. Their offerings are widely used in peptide synthesis and pharmaceutical applications across the continent.

Innovation Initiatives:

• Investment in high-purity reagent technologies

• Expansion of portfolio for biotechnology applications

---

7️⃣ 4. Lonza Group

Headquarters: Basel, Switzerland
Key Offering: N-Hydroxysuccinimide reagents, custom synthesis services

Lonza Group is a leading contract development and manufacturing organization with strong capabilities in specialty reagents. The company supports both clinical and commercial stages of pharmaceutical development with reliable NHS supply.

Innovation Initiatives:

• Integrated solutions for peptide therapeutics

• State-of-the-art manufacturing facilities in Europe

Download FREE Sample Report: Europe N-Hydroxysuccinimide Market – View in Detailed Research Report

---

6️⃣ 5. Solvay SA

Headquarters: Brussels, Belgium
Key Offering: Specialty organic compounds and intermediates including NHS

Solvay SA brings decades of expertise in specialty chemicals to the N-Hydroxysuccinimide market. Their products meet the stringent requirements of pharmaceutical and cosmetic manufacturers throughout Europe.

Innovation Initiatives:

• Advanced process optimization for reagent purity

• Sustainability-focused manufacturing practices

---

5️⃣ 6. Clariant AG

Headquarters: Muttenz, Switzerland
Key Offering: High-performance chemical intermediates for life sciences

Clariant AG delivers innovative specialty chemicals that support key applications in pharmaceuticals and personal care. Their N-Hydroxysuccinimide offerings benefit from strong quality control and technical support.

Innovation Initiatives:

• Focus on eco-friendly chemical processes

• Customer-centric development programs

---

4️⃣ 7. Symrise AG

Headquarters: Holzminden, Germany
Key Offering: Specialty ingredients and chemical building blocks

Symrise AG combines its strengths in flavor, fragrance, and cosmetic ingredients with capabilities in biochemical reagents. The company contributes significantly to Europe’s cosmetics and pharmaceutical supply chains.

Innovation Initiatives:

• Development of multifunctional ingredients

• Investment in biotechnology platforms

---

3️⃣ 8. Lanxess AG

Headquarters: Cologne, Germany
Key Offering: Specialty chemicals and intermediates for industrial applications

Lanxess AG provides essential chemical components that support various synthesis processes, including those involving N-Hydroxysuccinimide in research and scale-up production.

Innovation Initiatives:

• High-efficiency production methods

• Commitment to responsible chemical management

---

2️⃣ 9. Arkema S.A.

Headquarters: Colombes, France
Key Offering: Advanced materials and specialty chemical intermediates

Arkema S.A. offers a range of solutions for the fine chemicals sector, supporting the growing needs of the European pharmaceutical industry with reliable reagent supply.

Innovation Initiatives:

• Research into next-generation synthesis aids

• Expansion in high-value specialty segments

Download FREE Sample Report: Europe N-Hydroxysuccinimide Market – View in Detailed Research Report

---

1️⃣ 10. Covestro AG

Headquarters: Leverkusen, Germany
Key Offering: Specialty chemical solutions and intermediates

Covestro AG applies its polymer and chemical expertise to deliver components vital for advanced biochemical applications. The company supports innovation in Europe’s dynamic life sciences landscape.

Innovation Initiatives:

• Sustainable chemistry development programs

• Strategic alliances with research organizations

Get Full Report Here: Europe N-Hydroxysuccinimide Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Europe N-Hydroxysuccinimide Market Is Innovative and Sustainable

The Europe N-Hydroxysuccinimide market is experiencing steady expansion driven by rising demand in pharmaceutical research and biotechnology applications. While traditional synthesis methods remain important, the industry is investing in higher purity standards, improved production efficiency, and greener chemical processes.

📈 Key Trends Shaping the Market:

• Growing adoption in peptide-based drug development

• Increasing demand from cosmetics and personal care sectors

• Advancements in high-purity reagent manufacturing

• Strong collaboration between industry and academic research

Get Full Report Here: Europe N-Hydroxysuccinimide Market – View in Detailed Research Report

The companies listed above are not only supplying critical reagents—they are enabling the next generation of scientific breakthroughs across Europe.